The non invasive neurostimulation devices market size has grown rapidly in recent years. It will grow from $1.89 billion in 2025 to $2.14 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to limited availability of non-invasive neurostimulation devices, reliance on conventional pain management therapies, slow adoption in homecare settings, growing awareness of neurological disorders, limited clinical research and validation.
The non invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to technological advancements in tDCS and EMS devices, rising prevalence of chronic pain and neurological disorders, growing adoption of homecare neurostimulation solutions, increasing investment in clinical research and academic studies, integration of AI and smart monitoring in neurostimulation devices. Major trends in the forecast period include rising adoption of non-invasive pain management therapies, expansion of homecare neurostimulation devices, integration of wearable and portable neurostimulation solutions, increasing clinical research and academic studies on neurostimulation, focus on personalized and targeted neurostimulation treatments.
The increasing prevalence of neurological disorders is expected to propel the growth of the non-invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The growing occurrence of these conditions is closely linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of neurological issues. Non-invasive neurostimulation devices assist in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They provide non-surgical, real-time evaluation methods, improving diagnostic accuracy and enhancing patient care in both clinical and home settings. For example, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia - a progressive brain disorder affecting memory, thinking, and daily activities - by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. This rise in neurological disorders is thereby contributing significantly to the growth of the non-invasive neurostimulation devices market.
Major companies operating in the non-invasive neurostimulation devices market are focusing on developing advanced products such as personalized stimulation protocols to enhance treatment effectiveness and patient outcomes. Personalized stimulation protocols involve tailoring neurostimulation settings to an individual’s specific medical condition, neural response, and treatment goals to maximize therapeutic benefits while minimizing side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, introduced a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative solution enables healthcare professionals to supervise therapy sessions remotely, improving accessibility and treatment adherence for patients with neurological and mental health conditions like depression and chronic pain.
In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. This acquisition allowed ElectroCore to expand its portfolio in non-invasive neuromodulation by incorporating NeuroMetrix’s Quell pain relief device and DPNCheck diagnostic tool, strengthening its position in the field of bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company that specializes in non-invasive neurostimulation devices.
Major companies operating in the non invasive neurostimulation devices market are Alpha Stim, Neurosoft Bioelectronics SA, Neuronetics Inc, BrainsWay Ltd, eNeura Inc, MagVenture A S, Nexstim Plc, Neuroelectrics Barcelona S L U, Cefaly Technology, ElectroCore Inc, Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc, Sooma Medical, NeuroSigma Inc, Mind Alive Inc, TheBrainDriver LLC, Caputron Medical Products LLC, Soterix Medical Inc, neuroConn GmbH, Halo Neuroscience Inc, BTL Industries Inc, Zimmer MedizinSysteme GmbH.
North America was the largest region in the non invasive neurostimulation devices market in 2025. The regions covered in the non invasive neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non invasive neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the non-invasive neurostimulation devices market by increasing costs for imported components such as electrodes, stimulators, and wearable device parts. Segments including TENS, TMS, and EMS devices are most impacted, particularly in regions like Asia-Pacific and Europe where imports constitute a significant share of supply. While tariffs have raised production costs and slowed device availability, they have also encouraged local manufacturing, innovation in cost-effective components, and regional supply chain diversification.
The non invasive neurostimulation devices market research report is one of a series of new reports that provides non invasive neurostimulation devices market statistics, including non invasive neurostimulation devices industry global market size, regional shares, competitors with a non invasive neurostimulation devices market share, detailed non invasive neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the non invasive neurostimulation devices industry. This non invasive neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Non-invasive neurostimulation devices are advanced medical technologies developed to influence neural activity without the need for surgical procedures. These devices utilize external techniques such as electrical, magnetic, or ultrasonic stimulation to focus on particular regions of the nervous system. Their primary objective is to treat neurological and psychiatric disorders like chronic pain, depression, and epilepsy by modifying brain or nerve activity in a safe and efficient manner.
The primary categories of non-invasive neurostimulation devices include transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. TENS involves the use of low-voltage electrical pulses delivered through the skin using electrodes as a method for non-invasive pain relief. These devices are employed across a variety of clinical applications such as pain management, neurological and psychological disorders, among others. They serve different end users including hospitals and clinics, homecare settings, and academic or research institutions.
The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The non invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to technological advancements in tDCS and EMS devices, rising prevalence of chronic pain and neurological disorders, growing adoption of homecare neurostimulation solutions, increasing investment in clinical research and academic studies, integration of AI and smart monitoring in neurostimulation devices. Major trends in the forecast period include rising adoption of non-invasive pain management therapies, expansion of homecare neurostimulation devices, integration of wearable and portable neurostimulation solutions, increasing clinical research and academic studies on neurostimulation, focus on personalized and targeted neurostimulation treatments.
The increasing prevalence of neurological disorders is expected to propel the growth of the non-invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The growing occurrence of these conditions is closely linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of neurological issues. Non-invasive neurostimulation devices assist in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They provide non-surgical, real-time evaluation methods, improving diagnostic accuracy and enhancing patient care in both clinical and home settings. For example, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia - a progressive brain disorder affecting memory, thinking, and daily activities - by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. This rise in neurological disorders is thereby contributing significantly to the growth of the non-invasive neurostimulation devices market.
Major companies operating in the non-invasive neurostimulation devices market are focusing on developing advanced products such as personalized stimulation protocols to enhance treatment effectiveness and patient outcomes. Personalized stimulation protocols involve tailoring neurostimulation settings to an individual’s specific medical condition, neural response, and treatment goals to maximize therapeutic benefits while minimizing side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, introduced a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative solution enables healthcare professionals to supervise therapy sessions remotely, improving accessibility and treatment adherence for patients with neurological and mental health conditions like depression and chronic pain.
In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. This acquisition allowed ElectroCore to expand its portfolio in non-invasive neuromodulation by incorporating NeuroMetrix’s Quell pain relief device and DPNCheck diagnostic tool, strengthening its position in the field of bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company that specializes in non-invasive neurostimulation devices.
Major companies operating in the non invasive neurostimulation devices market are Alpha Stim, Neurosoft Bioelectronics SA, Neuronetics Inc, BrainsWay Ltd, eNeura Inc, MagVenture A S, Nexstim Plc, Neuroelectrics Barcelona S L U, Cefaly Technology, ElectroCore Inc, Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc, Sooma Medical, NeuroSigma Inc, Mind Alive Inc, TheBrainDriver LLC, Caputron Medical Products LLC, Soterix Medical Inc, neuroConn GmbH, Halo Neuroscience Inc, BTL Industries Inc, Zimmer MedizinSysteme GmbH.
North America was the largest region in the non invasive neurostimulation devices market in 2025. The regions covered in the non invasive neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non invasive neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the non-invasive neurostimulation devices market by increasing costs for imported components such as electrodes, stimulators, and wearable device parts. Segments including TENS, TMS, and EMS devices are most impacted, particularly in regions like Asia-Pacific and Europe where imports constitute a significant share of supply. While tariffs have raised production costs and slowed device availability, they have also encouraged local manufacturing, innovation in cost-effective components, and regional supply chain diversification.
The non invasive neurostimulation devices market research report is one of a series of new reports that provides non invasive neurostimulation devices market statistics, including non invasive neurostimulation devices industry global market size, regional shares, competitors with a non invasive neurostimulation devices market share, detailed non invasive neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the non invasive neurostimulation devices industry. This non invasive neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Non-invasive neurostimulation devices are advanced medical technologies developed to influence neural activity without the need for surgical procedures. These devices utilize external techniques such as electrical, magnetic, or ultrasonic stimulation to focus on particular regions of the nervous system. Their primary objective is to treat neurological and psychiatric disorders like chronic pain, depression, and epilepsy by modifying brain or nerve activity in a safe and efficient manner.
The primary categories of non-invasive neurostimulation devices include transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. TENS involves the use of low-voltage electrical pulses delivered through the skin using electrodes as a method for non-invasive pain relief. These devices are employed across a variety of clinical applications such as pain management, neurological and psychological disorders, among others. They serve different end users including hospitals and clinics, homecare settings, and academic or research institutions.
The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Non Invasive Neurostimulation Devices Market Characteristics
3. Non Invasive Neurostimulation Devices Market Supply Chain Analysis
4. Global Non Invasive Neurostimulation Devices Market Trends and Strategies
5. Non Invasive Neurostimulation Devices Market Analysis of End Use Industries
7. Global Non Invasive Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Non Invasive Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Non Invasive Neurostimulation Devices Market Segmentation
10. Non Invasive Neurostimulation Devices Market Regional and Country Analysis
11. Asia-Pacific Non Invasive Neurostimulation Devices Market
12. China Non Invasive Neurostimulation Devices Market
13. India Non Invasive Neurostimulation Devices Market
14. Japan Non Invasive Neurostimulation Devices Market
15. Australia Non Invasive Neurostimulation Devices Market
16. Indonesia Non Invasive Neurostimulation Devices Market
17. South Korea Non Invasive Neurostimulation Devices Market
18. Taiwan Non Invasive Neurostimulation Devices Market
19. South East Asia Non Invasive Neurostimulation Devices Market
20. Western Europe Non Invasive Neurostimulation Devices Market
21. UK Non Invasive Neurostimulation Devices Market
22. Germany Non Invasive Neurostimulation Devices Market
23. France Non Invasive Neurostimulation Devices Market
24. Italy Non Invasive Neurostimulation Devices Market
25. Spain Non Invasive Neurostimulation Devices Market
26. Eastern Europe Non Invasive Neurostimulation Devices Market
27. Russia Non Invasive Neurostimulation Devices Market
28. North America Non Invasive Neurostimulation Devices Market
29. USA Non Invasive Neurostimulation Devices Market
30. Canada Non Invasive Neurostimulation Devices Market
31. South America Non Invasive Neurostimulation Devices Market
32. Brazil Non Invasive Neurostimulation Devices Market
33. Middle East Non Invasive Neurostimulation Devices Market
34. Africa Non Invasive Neurostimulation Devices Market
36. Non Invasive Neurostimulation Devices Market Competitive Landscape and Company Profiles
37. Non Invasive Neurostimulation Devices Market Other Major and Innovative Companies
40. Non Invasive Neurostimulation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Non Invasive Neurostimulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses non invasive neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for non invasive neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non invasive neurostimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type Of Stimulation Technology: Transcutaneous Electrical Nerve Stimulation (TENS); Transcranial Magnetic Stimulation (TMS); Electromagnetic Stimulation (EMS); Other Types Of Stimulation Technologies2) By Target Indication: Pain Management; Neurological Disorders; Psychological Disorder; Other Target Indications
3) By End User: Hospitals And Clinics; Homecare Settings; Research And Academic Institutes
Subsegments:
1) By Transcutaneous Electrical Nerve Stimulation (TENS): Conventional Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS); Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS); Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS)2) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS); Deep Transcranial Magnetic Stimulation (dTMS); Single-Pulse Transcranial Magnetic Stimulation; Paired-Pulse Transcranial Magnetic Stimulation
3) By Electromagnetic Stimulation (EMS): Functional Electromagnetic Stimulation (EMS); Neuromuscular Electromagnetic Stimulation (EMS); High-Frequency Electromagnetic Stimulation (EMS); Low-Frequency Electromagnetic Stimulation (EMS)
4) By Other Types Of Stimulation Technology: Transcranial Direct Current Stimulation (tDCS); Cranial Electrotherapy Stimulation (CES)
Companies Mentioned: Alpha Stim; Neurosoft Bioelectronics SA; Neuronetics Inc; BrainsWay Ltd; eNeura Inc; MagVenture A S; Nexstim Plc; Neuroelectrics Barcelona S L U; Cefaly Technology; ElectroCore Inc; Brainbox India Private Limited; Flow Neuroscience AB; Fisher Wallace Laboratories Inc; Sooma Medical; NeuroSigma Inc; Mind Alive Inc; TheBrainDriver LLC; Caputron Medical Products LLC; Soterix Medical Inc; neuroConn GmbH; Halo Neuroscience Inc; BTL Industries Inc; Zimmer MedizinSysteme GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Non Invasive Neurostimulation Devices market report include:- Alpha Stim
- Neurosoft Bioelectronics SA
- Neuronetics Inc
- BrainsWay Ltd
- eNeura Inc
- MagVenture A S
- Nexstim Plc
- Neuroelectrics Barcelona S L U
- Cefaly Technology
- ElectroCore Inc
- Brainbox India Private Limited
- Flow Neuroscience AB
- Fisher Wallace Laboratories Inc
- Sooma Medical
- NeuroSigma Inc
- Mind Alive Inc
- TheBrainDriver LLC
- Caputron Medical Products LLC
- Soterix Medical Inc
- neuroConn GmbH
- Halo Neuroscience Inc
- BTL Industries Inc
- Zimmer MedizinSysteme GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.14 Billion |
| Forecasted Market Value ( USD | $ 3.45 Billion |
| Compound Annual Growth Rate | 12.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
